XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 150,279 $ 202,004
Marketable securities available-for-sale 592,023 422,391
Accounts receivables, net of allowance for doubtful accounts of $12,313 and $0 at December 31, 2023 and December 31, 2022, respectively 40,607 145,130
Other receivables 3,926 2,385
Inventories 53,290 59,446
Prepaid expenses and other current assets 18,995 85,629
Total current assets 859,120 916,985
Property and equipment, net 37,297 37,596
Operating lease right-of-use assets 24,287 25,745
Goodwill 2,067 2,006
Other assets (Note 9 ) 74,325 3,518
Total assets 997,096 985,850
Current liabilities:    
Accounts payable 5,245 3,211
Accrued research and development 2,982 4,775
CEPI accrual (Note 9) 0 107,738
Accrued liabilities (Note 7) 49,448 30,719
Other current liabilities 4,520 3,631
Total current liabilities 62,195 150,074
Convertible Notes, net of debt discount of $2,802 and $3,922 at December 31, 2023 and December 31, 2022, respectively (Note 10) 222,698 221,578
Long-term portion of lease liabilities 29,720 32,801
CEPI accrual long-term (Note 9) 60,337 0
Other long-term liabilities 74 384
Total liabilities 375,024 404,837
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Preferred stock: $0.001 par value, 5,000 shares authorized at December 31, 2023, and 2022; zero shares outstanding at December 31, 2023 and 2022 0 0
Common stock: $0.001 par value; 278,000 shares authorized at December 31, 2023, and 2022; 129,530 shares and 127,604 shares issued and outstanding at December 31, 2023 and 2022, respectively 130 128
Additional paid-in capital 1,554,634 1,510,518
Accumulated other comprehensive loss (2,108) (5,438)
Accumulated deficit (930,584) (924,195)
Total stockholders’ equity 622,072 581,013
Total liabilities and stockholders’ equity $ 997,096 $ 985,850